🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tumor hypoxia is one of the physiological factors for treatment resistance ...
Status
Recruiting
Location
University of Utah
Start Date
2024-06-28
Trial ID
NCT06108089
Treatments Being Tested
Background: \- Treatment for liver cancer can include surgery, transplant,...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-06-12
Trial ID
NCT02471313
Treatments Being Tested
Background : In malignant gliomas, hypoxia is associated with tumour angio...
Status
Completed
Location
Caen University Hospital
Start Date
2010-10
Trial ID
NCT01200134
Treatments Being Tested
Idiopathic pulmonary fibrosis (IPF) is a rare, chronic, lethal disease of u...
Status
Completed
Location
Chu Dijon Bourgogne
Start Date
2023-03-20
Trial ID
NCT05331729
Treatments Being Tested
Nasopharyngeal carcinoma (NPC) differs from other head and neck malignancie...
Status
Unknown
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT02089204
Treatments Being Tested
The goal of this prospective clinical trial is to determine if HPV-associat...
Status
Recruiting
Location
Northern Sydney Cancer Centre, Royal North Shore Hospital
Start Date
2025-04-01
Trial ID
NCT06307015
Treatments Being Tested
The researchers are doing this study is to find out if lower doses (given i...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-05-13
Trial ID
NCT06984861
Treatments Being Tested
In this research study, the investigators are using FMISO-PET and MRI scans...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-02
Trial ID
NCT02076152
Treatments Being Tested
The purpose of the study is to see if using an investigational drug called ...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2022-03-25
Trial ID
NCT04332588
Treatments Being Tested
This phase II trial studies cediranib maleate in combination with olaparib ...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2016-08-31
Trial ID
NCT02498613